NCT00836472View on ClinicalTrials.gov

Glyburide/Metformin 5 mg/500 mg Film-Coated Tablets, Fasting

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

April 30, 2003

Study Completion Date

April 30, 2003

Conditions
Healthy
Interventions
DRUG

Glyburide/Metformin 5 mg/500 mg Tablets

1 x 5 mg/500 mg, single-dose fasting

DRUG

Glucovance® 5 mg/500 mg Tablets

1 x 5 mg/500 mg, single-dose fasting

Trial Locations (1)

GIV2K8

Anapharm Inc., Sainte-Foy

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00836472 - Glyburide/Metformin 5 mg/500 mg Film-Coated Tablets, Fasting | Biotech Hunter | Biotech Hunter